Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Cgfj5xv
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Multidrug-resistant tuberculosis drug, Pretomanid, reduced by 34%
https://ift.tt/tzj948y
No comments:
Post a Comment